Whether the observed effect could be reproduced in MYCN-nonamplified but MYC overexpressing NB cells and thus explain the synergistic effect of CDK7 and BRD4 inhibition remains to be seen in future studies. The gene discussed is MYCN; the disease is neuroblastoma.